Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of VET3-TGI in Patients With Solid TumorsFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, adenoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cervix disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, head and neck squamous cell carcinoma, kidney cancer, kidney disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, mesothelial neoplasm, mesothelioma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, squamous cell neoplasm, urinary system disorder, uterine disorderRecruitingPhase 12026-04-07NCT06444815

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
KaliVir Immunotherapeutics1

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Community Health NetworkIndianapolisUnited States16
Mary Crowley Cancer ResearchDallasUnited States29
UC Irvine HealthOrangeUnited States20
University of MiamiMiamiUnited States327
University of Texas MD Anderson Cancer CenterHoustonUnited States192
UPMC- Hillman Cancer CenterPittsburghUnited States1
USC/Norris Comprehensive Cancer CenterLos AngelesUnited States35